Literature DB >> 1627810

Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.

R Storb, M Pepe, H J Deeg, C Anasetti, F R Appelbaum, W Bensinger, C D Buckner, R A Cliff, K Doney, J Hansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1627810

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  Exposure-effect population model of inolimomab, a monoclonal antibody administered in first-line treatment for acute graft-versus-host disease.

Authors:  Céline Dartois; Gilles Freyer; Mauricette Michallet; Emilie Hénin; Benoît You; Isabelle Darlavoix; Claudine Vermot-Desroches; Brigitte Tranchand; Pascal Girard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 3.  Post-transplant cyclophosphamide use in matched HLA donors: a review of literature and future application.

Authors:  Riad El Fakih; Shahrukh K Hashmi; Stephen O Ciurea; Leo Luznik; Robert Peter Gale; Mahmoud Aljurf
Journal:  Bone Marrow Transplant       Date:  2019-05-14       Impact factor: 5.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.